Clinical trial
CRYSTAL Study: A Multi-Center, Randomized, Controlled Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries.
NCT03423511 is registered in ClinicalTrials.gov with Micell Technologies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CRYSTAL Study: A Multi-Center, Randomized, Controlled Trial to Demonstrate the Safety and Effectiveness of the MiStent II for the Revascularization of Coronary Arteries.
- Lead sponsor
- Micell Technologies
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- December 31, 2021
- Completion date
- June 1, 2027
- Enrollment
- 1,300 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.